### Change History

The following is a list of all the changes based on versions.

### Changes made from STU 1 to STU 2 (Ballot)

#### Addressed the following Jira Tickets:

|JIRA Ticket|Ticket Description|
|---------|----------|
|[FHIR-51469](https://jira.hl7.org/browse/FHIR-51469) | Update to align with USCDI V3/US Core 6.1.0 |

#### Detailed Description of Changes:

<table border="1">
    <thead>
       <tr style="background-color:#DCDCDC">
            <th style="text-align: center; vertical-align: middle;">Artifact</th>
            <th style="text-align: center; vertical-align: middle;">Change Description</th>
        </tr>
    </thead>
    <tbody>
        <tr>
            <td>All</td>
            <td>Aligned with <a href="https://hl7.org/fhir/us/core/STU6.1/index.html">US Core 6.1.0</a></td>
        </tr>
        <tr>
            <td>All (where applicable)</td>
            <td>Removed references to MedMorph Reference Architecture IG</td>
        </tr>
         <tr>
            <td>All (where applicable)</td>
            <td>Added references to US PH Library profiles</td>
        </tr>
        <tr>
            <td><a href="StructureDefinition-resp-net-composition.html">RESP-NET Composition</a></td>
            <td>Added Encounter section</td>
        </tr>
    </tbody>
</table>

### Changes made from STU 1 (Ballot) to STU 1

#### Addressed the following Jira Tickets:

|JIRA Ticket|Ticket Description|
|---------|----------|
|[FHIR-45328](https://jira.hl7.org/browse/FHIR-45328) | Tag bundles to identify which use case is being reported |
|[FHIR-45327](https://jira.hl7.org/browse/FHIR-45327) | Support Catchment Area |
|[FHIR-44524](https://jira.hl7.org/browse/FHIR-44524) | Revise Introduction to include other approaches than MedMorph RA |
|[FHIR-44516](https://jira.hl7.org/browse/FHIR-44516) | Clarify sections included in profile content table and not in the Intro section |
|[FHIR-44513](https://jira.hl7.org/browse/FHIR-44513) | Revise workflow to incorporate De-Identification and use UDS+ approach |
|[FHIR-44025](https://jira.hl7.org/browse/FHIR-44025) | Clarify scope of catchment area |
|[FHIR-44024](https://jira.hl7.org/browse/FHIR-44024) | Clarify scope to include test RESULTS available in hospital system |
|[FHIR-43823](https://jira.hl7.org/browse/FHIR-43823) | Fix Update Capability Statement description |
|[FHIR-43680](https://jira.hl7.org/browse/FHIR-43680) | Data for the disease burden project are not anonymous to the RESP-NET site |
|[FHIR-43679](https://jira.hl7.org/browse/FHIR-43679) | Consider adding a hospital identifier |
|[FHIR-43678](https://jira.hl7.org/browse/FHIR-43678) | Section's title should be changed for consistent terminology throughout |
|[FHIR-43677](https://jira.hl7.org/browse/FHIR-43677) | Can the system distinguish between patient discharge vs. patient transfer to another hospital? |
|[FHIR-43676](https://jira.hl7.org/browse/FHIR-43676) | Restate description for Use Cases 4 and 5 |
|[FHIR-43675](https://jira.hl7.org/browse/FHIR-43675) | Evaluate the consistency of using "case" |
|[FHIR-43604](https://jira.hl7.org/browse/FHIR-43604) | References to MedMorph create ambiguity |
|[FHIR-43598](https://jira.hl7.org/browse/FHIR-43598) | Subscription requirement |
|[FHIR-43584](https://jira.hl7.org/browse/FHIR-43584) | Focus IG on Knowledge and Content |
|[FHIR-43534](https://jira.hl7.org/browse/FHIR-43534) | Data Element Requirements |
|[FHIR-43532](https://jira.hl7.org/browse/FHIR-43532) | Editorial Updates in 7.1.1 CapabilityStatement |
|[FHIR-43503](https://jira.hl7.org/browse/FHIR-43503) | Clarify the Pregnancy Outcome entry |
|[FHIR-43502](https://jira.hl7.org/browse/FHIR-43502) | Content missing from the Composition profile narrative |
|[FHIR-43500](https://jira.hl7.org/browse/FHIR-43500) | Clarify placement of DiagnosticReport in the Composition |
|[FHIR-43498](https://jira.hl7.org/browse/FHIR-43498) | Possible duplicate entry in Composition narrative |
|[FHIR-43497](https://jira.hl7.org/browse/FHIR-43497) | Clarify use of MedicationReference slice |
|[FHIR-43496](https://jira.hl7.org/browse/FHIR-43496) | Clarify usage of Medication resources in Composition profile |
|[FHIR-43495](https://jira.hl7.org/browse/FHIR-43495) | Clarify the nature of requirements in the Composition profile narrative |
|[FHIR-43493](https://jira.hl7.org/browse/FHIR-43493) | Please confirm the use of the Composition.type LOINC code |
|[FHIR-43492](https://jira.hl7.org/browse/FHIR-43492) | Clarify the 72 hours threshold after encounter close |
|[FHIR-43491](https://jira.hl7.org/browse/FHIR-43491) | Missing word in Section 3.4.5 |
|[FHIR-43490](https://jira.hl7.org/browse/FHIR-43490) | Figure text overlaps a line |
|[FHIR-43489](https://jira.hl7.org/browse/FHIR-43489) | Inconsistency in COVID references  |
|[FHIR-43486](https://jira.hl7.org/browse/FHIR-43486) | Clarify reporting requirement time frame |
|[FHIR-43485](https://jira.hl7.org/browse/FHIR-43485) | Alignment of Use Cases 1,2 and 3 |
|[FHIR-43462](https://jira.hl7.org/browse/FHIR-43462) | Clarify monitoring of positive patients |
|[FHIR-43461](https://jira.hl7.org/browse/FHIR-43461) | Remove references to BSA |

### Changes for STU 1 (Ballot)

#### Detailed Description of Changes:
Initial version of the IG.
